ScholarIQanswers from OpenAlex

308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome

PaperCitations, authors & open-access status

308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome is a paper indexed in ScholarIQ from OpenAlex.

How many citations does 308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome have?

ScholarIQcitation count

308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome has 0 citations in the OpenAlex counts ScholarIQ stores.

When was 308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome published?

ScholarIQyear

308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome has 2019 year in the ScholarIQ index.

What is the open-access status of 308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome?

ScholarIQoa status

308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome has closed oa status in the ScholarIQ index.

What is the DOI of 308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome?

ScholarIQdoi

The DOI for 308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome is on the source record.

What is the OpenAlex record for 308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome?

ScholarIQopenalex

The OpenAlex for 308 – Teduglutide in a Real World Setting Significantly Reduces the Risk of Hospitalization Without Increase in Long-Term Complications in Patients with Short Bowel Syndrome is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial